Juxtarenal Aortic Aneurysm
- Conditions
- Juxtarenal AneurysmsOpen Repair
- Registration Number
- NCT06988345
- Lead Sponsor
- University Hospital Muenster
- Brief Summary
All patients with a juxtarenal abdominal aortic aneurysm who underwent open aneurysm therapy between January 2010 and July 2020 were included retrospectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 200
- Patients with a juxtarenal aneurysm (defined as infrarenal neck <10mm and clamping above at least one renal artery [31592091])
- Open therapy with infrarenal (Anschluss)
- >18 years
- Patients with an anastomosis above the renal arteries (e.g. including bypass to a renal artery)
- Patients with supravisceral clamping
- Patients with reconstruction of the aorta in the suprarenal area
- Patients with connective tissue diseases (e.g. Marfan syndrome or Ehler Danlos syndrome)
- Post-dissection aneurysms
- Infected aneurysms
- Conversions after endovascular therapy
- Inflammatory aneurysms
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality 30 days after intervention Mortality after 30 days postop
Acute renal failure 30 days after intervention Acute renal failure postoperatively, defined by KDIGO criteria of AKI \[22890468\]
- Secondary Outcome Measures
Name Time Method Post-operative complication rates During Follow-up period (up to 13 years) Post-operative complication rates:
* cardiac
* pulmonal
* mesenterial
* neurological
* access-associated
* re-interventionDialysis during Follow up period, checked every year Permanent dialysis required
Reinterventions during Follow up period, checked every year Rates of Reinterventions
Mortality during Follow up period (up to 13 years) Overall mortality
Aneurysm-related Mortality during Follow up period (up to 13 years) Aneurysm-related Mortality
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.